Other ILC subsets, such as CD4(+) ILC1, CD5(+) mature ILC1, immature ILCs, and LT-ILC155, may also play important roles in FAP-related tumorigenesis and should be explored in future studies to further clarify the immune landscape of FAP adenomas. Here, CD5 is linked to adenoma.